ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2015, Vol. 24 ›› Issue (2): 117-122.

• 论文 • 上一篇    下一篇

低分子右旋糖酐导致肾病综合征患者急性肾损伤的临床病理特征及预后

  

  • 出版日期:2015-04-28 发布日期:2015-04-29

Clinicopathologic features and prognosis of nephrotic syndrome patients with AKI induced by low molecule dextran

  • Online:2015-04-28 Published:2015-04-29

摘要:

摘要 目的:回顾性分析肾病综合征(NS)患者使用低分子右旋糖苷(低右)所致急性肾损伤(acute kidney injury,AKI)的临床和病理特征,旨在提高对低右相关肾损害的认识。方法:选取2007年4月至2014年6月间,我院收治的20例外院诊断NS、使用低右后出现AKI的患者,排除其他药物、感染、尿路梗阻等因素导致的AKI。观察其临床表现、病理特点及预后。结果:(1)一般情况:20例患者中男性17例,女性3例,平均年龄26.70±14.18岁,肾脏病病程4(3~10)周,初发初治16例。起病时Scr 0.74±0.20mg/dl。均在外院诊断NS后使用低右治疗,通常剂量500ml/次(2~10次),AKI持续时间4.00±2.25周,发生AKI后60%患者出现贫血,24小时尿蛋白定量和尿沉渣红细胞计数显著增加(p<0.05),小管功能损伤明显,尿糖阳性率由5%上升至55%。(2)肾脏病理:肾脏原发病诊断足细胞病9例(45%),局灶节段性肾小球硬化7例(35%),IgA肾病2例(10%),膜性肾病1例(5%),IgM肾病1例(5%)。18例AKI时行肾活检术,16例合并急性肾小管坏死(ATN),2例合并急性间质性肾炎(AIN),15例近端肾小管上皮细胞见大量等立方空泡变性,15例出现肾小管上皮细胞扁平、刷状缘脱落,14例间质有炎症细胞浸润。(3)治疗:10例行连续性肾脏替代治疗,其中3例后续转为腹膜透析。原发病治疗激素有效(20%),激素依赖(25%),激素抵抗(30%)。(4)预后:5例出院时Scr恢复正常,10例随访1月内Scr正常,5例随访3月后肾功能未恢复,最终2例最终进入维持性透析。结论:NS患者使用低右可导致AKI,部分患者长期预后不佳。NS患者应慎用低右扩容。

关键词: 急性肾损伤, 低分子右旋糖苷, 不良反应

Abstract:

ABSTRACT Objective: To investigate the clinical and pathological features of acute kidney injury (AKI) following infusion of low molecule dextran (dextran 40) in patients with nephrotic syndrome (NS). Methodology: From April, 2007 to June, 2014, twenty NS patients were diagnosed as AKI because of infusing dextran 40. Other causes of AKI including other drugs, septic shock, urinary obstruction and so on were excluded. Their clinical and pathological features and prognosis were investigated. Results:They were 17males and 3 females, with an average of 26.7±14.2 years .The course of NS was 4weeks(ranged from 3.00 to 9.50). The primary glomerular disease of NS was MCD (45%), FSGS (35%), IgA nephropathy (10%), MN(5%) and IgM nephropathy (5%).Their initial serum creatinine (SCr) was 0.74±0.20mg/dl, and increased to 4.75±4.07(0.72~13.82)mg/dl after infusing with a usual dosage of Dextran 40 500ml/d(2~10d)for supplement blood volume. The duration of AKI was 4.00±2.25 weeks. Anemia was found in 60% of them, the quantity of proteinuria and urine sediment RBC were significantly increased after AKI(p<0.05), with prominent renal tubular function injury and high proportion of glycosuria(55%). The repeat renal biopsy was performed in 18 of them after AKI . Acute tubular necrosis (ATN) was diagnosed in 16 cases, and acute interstitial nephritis (AIN) in 2 cases. Vacuolation of the proximal tubular epithelium and brush border of lumen surface fell off were detected in 15 cases. Inflammatory cell infiltrations in interstitium were examined in 14 cases. Continuous renal replacement therapy was delivered to 10 cases. Prednisone was prescribed to the all cases. Complete remission was achieved in 20% of them and prednisone dependent in 25%. The levels of SCr were recovered to normal before discharging in 5 patients, and within one month in 10 patients. 3 patients were diagnosed as chronic kidney disease-stage 3, and 2 patients developed to ESRD one year after discharge. Conclusion: NS patient would suffer from AKI after administration of dextran 40, with poor prognosis in some of them. So the infusion of dextran 40 in patients with NS should be cautious.

Key words: acute kidney injury, dextran 40, nephrotic syndrome